{"id":84691,"date":"2026-06-15T15:45:10","date_gmt":"2026-06-15T15:45:10","guid":{"rendered":"https:\/\/www.europesays.com\/ch\/84691\/"},"modified":"2026-06-15T15:45:10","modified_gmt":"2026-06-15T15:45:10","slug":"advancing-precision-oncology-novartis-launches-indias-first-approved-radioligand-therapy-for-prostate-cancer","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/ch\/84691\/","title":{"rendered":"Advancing Precision Oncology Novartis Launches India\u2019s First Approved Radioligand Therapy for Prostate Cancer"},"content":{"rendered":"<p>            About Us<\/p>\n<p>\u2018Telugu Times\u2019 was started as the First Global Telugu Newspaper in USA in July 2003 by a team of<br \/>\n                Professionals with hands on experience and expertise in Media and Business in India and USA and<br \/>\n                has been serving the Non Resident Telugu community in USA as a media tool and Business &amp; Govt<br \/>\n                agencies as a Media vehicle. Today Telugu Times is a Media house in USA serving the community as<br \/>\n                a Print \/ ePaper editions on 1st and 16th of every month, a Portal with daily updates, an<br \/>\n                YouTube Channel with daily posts interesting video news, a Liaison agency between the NRI<br \/>\n                community and Telugu States, an Event coordinator\/organizer with a good presence in Facebook,<br \/>\n                Twitter, Instagram and WhatsApp groups etc. Telugu Times serves the Telugu community, the<br \/>\n                largest and also fast growing Indian community in USA functions as a Media Partner to all Telugu<br \/>\n                Associations and Groups , as a Connect with several major temples \/ Devasthanams in Telugu<br \/>\n                States. In its 20 th year, from 2023, Telugu Times started Business Excellence Awards , an<br \/>\n                Annual activity of recognizing and awarding Business Excellence of Telugu Entrepreneurs.<\/p>\n","protected":false},"excerpt":{"rendered":"About Us \u2018Telugu Times\u2019 was started as the First Global Telugu Newspaper in USA in July 2003 by&hellip;\n","protected":false},"author":2,"featured_media":84692,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_share_on_mastodon":"0"},"categories":[127],"tags":[35567,31490,100,43238,43146,206,40870,31818,24096,4117,43239,8514],"class_list":["post-84691","post","type-post","status-publish","format-standard","has-post-thumbnail","category-novartis","tag-cancer-care-india","tag-english-news","tag-latest-news","tag-medical-innovation","tag-metastatic-prostate-cancer","tag-novartis","tag-nuclear-medicine","tag-pluvicto","tag-precision-oncology","tag-prostate-cancer","tag-psma-positive","tag-radioligand-therapy"],"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@ch\/116754902224061059","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/posts\/84691","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/comments?post=84691"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/posts\/84691\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/media\/84692"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/media?parent=84691"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/categories?post=84691"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/tags?post=84691"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}